Physician profile
James W Shepard
NPI 1447284856
$1,807.58
in general payments reported to CMS, 2019-2025
17 companies · $13.91 in 2025
The $13.91 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $536 · 2020: $562 · 2021: $485 · 2022: $102 · 2023: $40.91 · 2024: $67.83 · 2025: $13.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $122.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $325.25 | 2019-2021 | |
| Viiv Healthcare Company | $257.17 | 2019-2024 | Dovato |
| Abbvie INC. | $212.84 | 2021-2023 | Vraylar |
| Allergan, INC. | $208.50 | 2019-2020 | |
| Janssen Products, LP | $196.44 | 2021-2022 | |
| Glaxosmithkline, LLC. | $163.49 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $119.95 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $88.11 | 2019-2021 | |
| Exact Sciences Corporation | $51.53 | 2023-2024 | Cologuard Collection Kit |
| Gilead Sciences, INC. | $49.50 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $40.43 | 2019-2021 | |
| Abbott Laboratories | $23.08 | 2024 | Freestyle Libre 3 |
| Hikma Pharmaceuticals USA | $17.38 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $16.61 | 2021 | |
| Napo Pharmaceuticals INC | $15.41 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $13.91 | 2025 | Artix Mt |
| Janssen Biotech, INC. | $7.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Shepard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.